Shaughnessy, J.

myeloma patient trial bortezomib sample therapy expression response blood risk strati fication study survival factor classi signi analysis disease erasmus mc outcome number fication gene expression genomic strati group prognostic j clin oncol treatment tumor speci system figure table consensus phase risk factors accuracy myeloma cells level plasma relapse erasmu br j haematol classi fier research diagnosis marrow feature 2012. article library cytogenetic information signi ficance survival classi fier gene expression data volume microglobulin model american society protein dataset signi ficantly probe sets signi ficant bortezomib trials blood myeloma purity score score subtype abnormality millennium pharmaceuticals subset dex arm cancer prediction ficant purity control gene sets value